Infinant Health Revenue and Competitors
Estimated Revenue & Valuation
- Infinant Health's estimated annual revenue is currently $5.1M per year.
- Infinant Health's estimated revenue per employee is $155,000
Employee Data
- Infinant Health has 33 Employees.
- Infinant Health grew their employee count by -49% last year.
Infinant Health's People
Name | Title | Email/Phone |
---|---|---|
1 | Office Manager/ Executive Assistant to CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Marketing Officer | Reveal Email/Phone |
4 | Chief Science Officer | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | Chief Marketing Officer | Reveal Email/Phone |
7 | SVP Finance and Controller | Reveal Email/Phone |
8 | VP, Clinical Implementation | Reveal Email/Phone |
9 | Director, Business Operations and Analytics | Reveal Email/Phone |
10 | Executive Director, Regulatory Affairs and Intellectual Property | Reveal Email/Phone |
Infinant Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Infinant Health?
Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of human milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to unintended consequences of modern medicine such as feeding and birthing practices. Now, there is a way to change that. What we found is that EVC001, our specific strain of B. infantis, is essential in developing a healthy microbiome, reducing potential harmful bacteria that may be linked to prevalent childhood issues such as allergies and type 1 diabetes, moderating inflammation, and supporting healthy immune system function. We believe the greatest chance to impact future health begins early, right after birth—a once in a lifetime opportunity where rapid development and radical changes occur. By unlocking human nutrition's full potential through introducing beneficial bacteria during early infancy, we can help build a foundation for better health.
keywords:N/AN/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
-49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.7M | 33 | -6% | N/A |
#2 | $3.8M | 33 | 10% | N/A |
#3 | $3.5M | 33 | 3% | N/A |
#4 | $5.5M | 33 | 3% | N/A |
#5 | $5.1M | 33 | 3% | N/A |